COSMOS Pharmaceutical CorporationJP:3349Balance sheet

Market cap
¥611.4B
P/E ratio
19.5x
2013/052014/052015/052016/052017/052018/052019/052020/052021/052022/052023/052024/052025/05
Cash and cash equivalents -21,30218,63527,28227,72821,66819,02252,12255,10837,36245,92852,30157,038
Total current assets-57,09758,42270,90573,74978,07380,385114,150125,125115,471137,085154,333165,622
Property, plant and equipment, net-69,14793,772114,463134,450153,976172,816185,374195,131225,286259,464295,798331,125
Marketable securities, non-current -22318454554444
Total non-current assets-85,603110,496131,690151,942172,535193,176206,132216,192247,581283,881322,213359,133
Total assets -142,700168,918202,595225,691250,609273,561320,283341,318363,052420,967476,546524,755
Short-term debt-1,2284,0154,9514,4863,1991,4861,4861,4861,3872,7414,581-
Long-term debt, current -1,2284,0154,9514,4863,1991,4861,4861,4861,3872,7414,5815,682
Total current liabilities-81,36289,624103,457114,132126,436133,170161,950159,537162,063192,053213,229220,680
Long-term debt, non-current -1,4808,17716,23411,7478,5487,0615,5744,0883,00010,01823,38537,202
Total non-current liabilities-6,93814,23822,95918,50615,28314,10112,65711,20310,48117,84231,87446,612
Total liabilities -88,301103,863126,416132,638141,720147,272174,607170,740172,545209,895245,104267,292
Common stock and paid-in capital -8,7888,7888,7888,7888,7888,7888,7888,7888,7888,7889,2799,279
Retained earnings-45,89956,54867,74584,575100,426117,829137,185162,065181,954202,485222,284248,309
Stockholders' equity44,95054,39965,05576,17993,053108,888126,289145,675170,578190,507211,072231,442257,463